ARCHIVES

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

This article is from The Cancer Letter archive.

Vol. 14 No. 47 | December 2, 1988

Download PDF Visit The Full Archive

Related Articles

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987